Liver Biopsy Market - Size, Share, Industry Trends, and Forecasts (2025-2032)

By Type:

Based on type, the market is categorized into percutaneous, laparoscopic, transvenous.

Trends in the Type:

• Development of flexible needles for better diagnosis is influencing the development of the segment.
• Rise in the trend for minimally invasive procedures, in influencing the segment.

The percutaneous segment accounted for the largest market share in 2024.

• Percutaneous liver biopsy is a minimally invasive procedure used to obtain a small sample of liver tissue for diagnostic purposes.
• It involves inserting a thin needle through the skin and into the liver, typically under the guidance of imaging techniques such as ultrasound, computed tomography (CT), or fluoroscopy.
• The needle is advanced into the liver parenchyma, and a small core of tissue is extracted.
• This tissue sample is then examined under a microscope by a pathologist to identify abnormalities such as inflammation, scarring, fatty infiltration, or the presence of cancer cells.
• Percutaneous liver biopsy is a valuable diagnostic tool for evaluating various liver diseases, including chronic hepatitis, cirrhosis, fatty liver disease, and liver tumors among others.

The transvenous segment is expected to grow at the fastest CAGR over the forecast period.

• Transvenous liver biopsy is a minimally invasive procedure that involves accessing the liver through a vein, typically the jugular vein in the neck.
• This approach differs from percutaneous liver biopsy, where the needle is inserted directly through the abdominal wall.
• By traversing the venous system, transvenous liver biopsy significantly reduces the risk of complications such as pneumothorax, a potential risk associated with percutaneous procedures that involve directly puncturing the liver parenchyma.
• This technique offers several advantages, including improved access to challenging liver segments and a reduced risk of complications, making it a valuable alternative for many patients requiring liver tissue sampling.
• Manufacturers are introducing novel biopsy kits for sampling liver tissues.
• For instance, Cook Medical has designed a specialized Liver Access and Biopsy Set, which is intended for use in medical procedures that involve accessing the liver for diagnostic. This comprehensive set includes various instruments and tools that facilitate safe and effective liver biopsies through the vein present in the neck region, enhancing the accuracy of the procedures while minimizing patient discomfort and risk.
• Thus, these aforementioned factors are influencing the liver biopsy market trends in the coming years.

By Indication:

Based on the indication, the market is categorized into chronic hepatitis B & C, non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, liver cirrhosis, and others.

Trends in Indication:

• The rise in use of biopsy for the diagnosis of hepatitis is influencing the segment

The non-alcoholic fatty liver disease (NAFLD) segment accounted for the largest market share in the year 2024 and is expected to grow at the fastest CAGR over the forecast period.

• Non-alcoholic fatty liver disease (NAFLD), characterized by the accumulation of excess fat in the liver in the absence of significant alcohol consumption.
• While imaging techniques like ultrasound and elastography provide valuable information, liver biopsy remains crucial for definitively diagnosing NAFLD and differentiating it from other liver diseases.
• Biopsy allows for histopathological evaluation, enabling the assessment of the severity of liver inflammation, the presence of fibrosis (scarring), and the presence of ballooning degeneration.
• This information is critical for guiding treatment decisions, predicting disease progression, and assessing the need for further interventions.
• The indication has become increasingly prevalent globally due to rising rates of obesity and type 2 diabetes.
• For instance, according to the data published by the Indian Journal of Community Medicine, in 2023, the prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) is significantly high globally, with estimates exceeding 25% of the adult population. In India, the prevalence of NAFLD ranges from 9% to 32% of the general population. This high prevalence is closely linked to the rising rates of obesity, type 2 diabetes, and metabolic syndrome, which are increasingly prevalent worldwide.
• Thus, as per the market analysis, the aforementioned factors are influencing the development of the liver biopsy market trends in the coming years.

By End-User:

Based on end user, the market is categorized into hospitals, diagnostic centers, ambulatory surgical centers, and others.

Trends in the End User:

• Expansion of diagnostic centers are influencing the segment
• Rise in the trend for same day procedures and discharge is influencing the segment.

The hospitals segment accounted for the largest market share of 58.89% in the year 2024.

• Hospitals play a pivotal role as end-users in the liver biopsy industry. They serve as the primary centers for performing these procedures, housing the necessary infrastructure, equipment, and expertise.
• Hospitals typically have dedicated departments of gastroenterology, hepatology, and interventional radiology, staffed with experienced physicians and trained technicians.
• These departments are equipped with advanced imaging modalities such as ultrasound, computed tomography (CT), and fluoroscopy, which are essential for guiding liver biopsy procedures.
• Furthermore, hospitals provide a comprehensive care setting, enabling the management of potential complications and ensuring patient safety and recovery following the procedure.
• Various hospitals are introducing novel biopsy procedures for proper sampling and early detection of indications.
• For instance, in 2024, Apollo Hospitals, announced the inauguration of its latest endeavor, the Apollo Fatty Liver Clinic at the Liver Diseases and Transplantation Institute, Apollo Hospital. This specialized clinic, equipped with state-of-the-art diagnostic tools like FibroScan for non-invasive assessment of liver fibrosis, will offer comprehensive care for individuals with fatty liver disease. The clinic will focus on early detection, accurate diagnosis, and personalized treatment plans, including lifestyle modifications, medication management, and advanced interventional procedures when necessary. It also includes liver biopsy that is necessary for definitive diagnosis and staging of liver disease. This comprehensive approach will ensure patients receive the most appropriate and effective care for their specific condition.
• Thus, based on the market analysis, these aforementioned factors are influencing the market demand.

The ambulatory surgical centers segment is expected to grow at the fastest CAGR over the forecast period.

• Ambulatory surgical centers (ASCs) are increasingly playing a significant role as end-users in the market.
• These facilities offer a cost-effective and convenient alternative to hospital settings for many minimally invasive procedures, including liver biopsies.
• ASCs are equipped with modern technology and staffed by experienced physicians and nurses, enabling them to perform a range of outpatient procedures safely and efficiently.
• The shift towards outpatient settings for liver biopsies offers several advantages, including reduced healthcare costs, improved patient convenience, and faster recovery times.
• Thus, based on the liver biopsy market analysis, the aforementioned factors are influencing segment growth in the coming years.